Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person NPM-ALK binds to FRS2 and FRS3 as assessed by co-immunopreci...

Class:IdSummation:9711766
_displayNameNPM-ALK binds to FRS2 and FRS3 as assessed by co-immunopreci...
_timestamp2023-10-14 19:29:17
created[InstanceEdit:9711762] Rothfels, Karen, 2021-01-13
modified[InstanceEdit:9851215] Rothfels, Karen, 2023-10-14
textNPM-ALK binds to FRS2 and FRS3 as assessed by co-immunoprecipitation from HEK293 cells. FRS proteins bind through three distinct sites, two of which (Y156 and Y567) are dependent on ALK tyrosine phosphorylation, while the third site encompassing residues 631-649 is phosphorylation independent. All three sites contribute to NPM-ALK-mediated transformation (Chikamori et al, 2007; Koshiba et al, 2010). FRS adaptor proteins may contribute to transformation by activating the MAP kinase or PI3K pathways but this has not been directly demonstrated in the case of ALK or ALK fusion signaling (reviewed in Palmer et al, 2009; Gotoh, 2008, Sato and Gotoh, 2009).
(summation)[Reaction:9712081] ALK fusions bind FRS [Homo sapiens]
[Change default viewing format]
No pathways have been reviewed or authored by NPM-ALK binds to FRS2 and FRS3 as assessed by co-immunopreci... (9711766)